1301 related articles for article (PubMed ID: 19047138)
1. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
[TBL] [Abstract][Full Text] [Related]
2. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
3. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy.
Kim SM; Oh JH; Park SA; Ryu CH; Lim JY; Kim DS; Chang JW; Oh W; Jeun SS
Stem Cells; 2010 Dec; 28(12):2217-28. PubMed ID: 20945331
[TBL] [Abstract][Full Text] [Related]
4. Cancer gene therapy using a novel secretable trimeric TRAIL.
Kim CY; Jeong M; Mushiake H; Kim BM; Kim WB; Ko JP; Kim MH; Kim M; Kim TH; Robbins PD; Billiar TR; Seol DW
Gene Ther; 2006 Feb; 13(4):330-8. PubMed ID: 16195699
[TBL] [Abstract][Full Text] [Related]
5. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
[TBL] [Abstract][Full Text] [Related]
6. CXCR4-transfected human umbilical cord blood-derived mesenchymal stem cells exhibit enhanced migratory capacity toward gliomas.
Park SA; Ryu CH; Kim SM; Lim JY; Park SI; Jeong CH; Jun JA; Oh JH; Park SH; Oh W; Jeun SS
Int J Oncol; 2011 Jan; 38(1):97-103. PubMed ID: 21109930
[TBL] [Abstract][Full Text] [Related]
7. Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells.
Lee DH; Ahn Y; Kim SU; Wang KC; Cho BK; Phi JH; Park IH; Black PM; Carroll RS; Lee J; Kim SK
Clin Cancer Res; 2009 Aug; 15(15):4925-34. PubMed ID: 19638465
[TBL] [Abstract][Full Text] [Related]
8. CXC chemokine receptor 1 enhances the ability of human umbilical cord blood-derived mesenchymal stem cells to migrate toward gliomas.
Kim SM; Kim DS; Jeong CH; Kim DH; Kim JH; Jeon HB; Kwon SJ; Jeun SS; Yang YS; Oh W; Chang JW
Biochem Biophys Res Commun; 2011 Apr; 407(4):741-6. PubMed ID: 21439934
[TBL] [Abstract][Full Text] [Related]
9. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
Nakamizo A; Marini F; Amano T; Khan A; Studeny M; Gumin J; Chen J; Hentschel S; Vecil G; Dembinski J; Andreeff M; Lang FF
Cancer Res; 2005 Apr; 65(8):3307-18. PubMed ID: 15833864
[TBL] [Abstract][Full Text] [Related]
10. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression.
Kim SK; Kim SU; Park IH; Bang JH; Aboody KS; Wang KC; Cho BK; Kim M; Menon LG; Black PM; Carroll RS
Clin Cancer Res; 2006 Sep; 12(18):5550-6. PubMed ID: 17000692
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model.
Nakamura K; Ito Y; Kawano Y; Kurozumi K; Kobune M; Tsuda H; Bizen A; Honmou O; Niitsu Y; Hamada H
Gene Ther; 2004 Jul; 11(14):1155-64. PubMed ID: 15141157
[TBL] [Abstract][Full Text] [Related]
12. Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy.
Grisendi G; Bussolari R; Cafarelli L; Petak I; Rasini V; Veronesi E; De Santis G; Spano C; Tagliazzucchi M; Barti-Juhasz H; Scarabelli L; Bambi F; Frassoldati A; Rossi G; Casali C; Morandi U; Horwitz EM; Paolucci P; Conte P; Dominici M
Cancer Res; 2010 May; 70(9):3718-29. PubMed ID: 20388793
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma.
Ryu CH; Park KY; Kim SM; Jeong CH; Woo JS; Hou Y; Jeun SS
Biochem Biophys Res Commun; 2012 May; 421(3):585-90. PubMed ID: 22525671
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy.
Hamada H; Kobune M; Nakamura K; Kawano Y; Kato K; Honmou O; Houkin K; Matsunaga T; Niitsu Y
Cancer Sci; 2005 Mar; 96(3):149-56. PubMed ID: 15771617
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy of intracranial glioma using interleukin 12-secreting human umbilical cord blood-derived mesenchymal stem cells.
Ryu CH; Park SH; Park SA; Kim SM; Lim JY; Jeong CH; Yoon WS; Oh WI; Sung YC; Jeun SS
Hum Gene Ther; 2011 Jun; 22(6):733-43. PubMed ID: 21261460
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells.
Kanehira M; Xin H; Hoshino K; Maemondo M; Mizuguchi H; Hayakawa T; Matsumoto K; Nakamura T; Nukiwa T; Saijo Y
Cancer Gene Ther; 2007 Nov; 14(11):894-903. PubMed ID: 17693990
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma.
Sonabend AM; Ulasov IV; Tyler MA; Rivera AA; Mathis JM; Lesniak MS
Stem Cells; 2008 Mar; 26(3):831-41. PubMed ID: 18192232
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor-transfected bone marrow stromal cells exhibit enhanced migratory response and therapeutic potential against murine brain tumors.
Sato H; Kuwashima N; Sakaida T; Hatano M; Dusak JE; Fellows-Mayle WK; Papworth GD; Watkins SC; Gambotto A; Pollack IF; Okada H
Cancer Gene Ther; 2005 Sep; 12(9):757-68. PubMed ID: 15832173
[TBL] [Abstract][Full Text] [Related]
19. Antitumor treatment using interleukin- 12-secreting marrow stromal cells in an invasive glioma model.
Hong X; Miller C; Savant-Bhonsale S; Kalkanis SN
Neurosurgery; 2009 Jun; 64(6):1139-46; discussion 1146-7. PubMed ID: 19487894
[TBL] [Abstract][Full Text] [Related]
20. Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice.
Gao Y; Yao A; Zhang W; Lu S; Yu Y; Deng L; Yin A; Xia Y; Sun B; Wang X
Oncogene; 2010 May; 29(19):2784-94. PubMed ID: 20190814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]